Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF)

Historical Holders from Q1 2023 to Q2 2025

Symbol
CANF on NYSE
CUSIP
13471N300
Type / Class
Equity / Ordinary Shares, no par value
Shares outstanding
3.84B
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
905K
Holdings value
$950K
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
15
Number of buys
7
Number of sells
-4
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Orca Capital AG 4.1% -56% $220M -$305M 157M -58% Orca Capital AG Apr 22, 2025
ARMISTICE CAPITAL, LLC 4.99% $617K 440K Armistice Capital, LLC Dec 31, 2024

Institutional Holders of Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 905K $950K +$805K $1.05 15
2025 Q1 131K $194K +$25K $1.48 13
2024 Q4 114K $186K -$1.33M $1.63 13
2024 Q3 754K $1.52M +$243K $2.01 11
2024 Q2 628K $1.62M +$393K $2.58 11
2024 Q1 478K $1.06M +$498K $2.22 8
2023 Q4 244K $536K +$353K $2.20 8
2023 Q3 67.6K $179K +$34.5K $2.65 7
2023 Q2 54.6K $168K -$705K $3.07 5
2023 Q1 368K $843K +$843K $2.29 6